Annual Total Expenses
$110.49 M
-$49.59 M-30.98%
December 31, 2023
Summary
- As of March 3, 2025, YMAB annual total expenses is $110.49 million, with the most recent change of -$49.59 million (-30.98%) on December 31, 2023.
- During the last 3 years, YMAB annual total expenses has fallen by -$30.19 million (-21.46%).
- YMAB annual total expenses is now -30.98% below its all-time high of $160.08 million, reached on December 31, 2022.
Performance
YMAB Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Expenses
$27.03 M
-$5.56 M-17.06%
September 30, 2024
Summary
- As of March 3, 2025, YMAB quarterly total expenses is $27.03 million, with the most recent change of -$5.56 million (-17.06%) on September 30, 2024.
- Over the past year, YMAB quarterly total expenses has stayed the same.
- YMAB quarterly total expenses is now -46.73% below its all-time high of $50.74 million, reached on June 30, 2022.
Performance
YMAB Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
YMAB Total Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -31.0% | 0.0% |
| 3 y3 years | -21.5% | -17.1% |
| 5 y5 years | +155.6% | -17.1% |
YMAB Total Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -31.0% | at low | -46.7% | +1.8% |
| 5 y | 5-year | -31.0% | +33.1% | -46.7% | +13.8% |
| alltime | all time | -31.0% | +548.5% | -46.7% | +603.5% |
Y-mAbs Therapeutics Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $27.03 M(-17.1%) |
| Jun 2024 | - | $32.59 M(+21.4%) |
| Mar 2024 | - | $26.84 M(+1.0%) |
| Dec 2023 | $110.49 M(-31.0%) | $26.56 M(-5.8%) |
| Sep 2023 | - | $28.20 M(+0.8%) |
| Jun 2023 | - | $27.97 M(+0.8%) |
| Mar 2023 | - | $27.75 M(-14.9%) |
| Dec 2022 | $160.08 M(+6.5%) | $32.60 M(-15.4%) |
| Sep 2022 | - | $38.55 M(-24.0%) |
| Jun 2022 | - | $50.74 M(+32.9%) |
| Mar 2022 | - | $38.18 M(-15.8%) |
| Dec 2021 | $150.33 M(+6.9%) | $45.36 M(+20.4%) |
| Sep 2021 | - | $37.67 M(+11.9%) |
| Jun 2021 | - | $33.66 M(+0.1%) |
| Mar 2021 | - | $33.64 M(-17.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2020 | $140.69 M(+69.5%) | $40.84 M(+25.1%) |
| Sep 2020 | - | $32.64 M(-19.3%) |
| Jun 2020 | - | $40.45 M(+51.2%) |
| Mar 2020 | - | $26.75 M(+12.6%) |
| Dec 2019 | $83.00 M(+92.0%) | $23.76 M(-2.5%) |
| Sep 2019 | - | $24.36 M(+30.7%) |
| Jun 2019 | - | $18.63 M(+14.6%) |
| Mar 2019 | - | $16.25 M(+15.4%) |
| Dec 2018 | $43.23 M(+124.6%) | $14.08 M(+23.3%) |
| Sep 2018 | - | $11.41 M(+11.3%) |
| Jun 2018 | - | $10.26 M(+37.2%) |
| Mar 2018 | - | $7.48 M(-19.4%) |
| Dec 2017 | $19.24 M(+12.9%) | $9.28 M(+141.4%) |
| Sep 2017 | - | $3.84 M |
| Dec 2016 | $17.04 M | - |
FAQ
- What is Y-mAbs Therapeutics annual total expenses?
- What is the all time high annual total expenses for Y-mAbs Therapeutics?
- What is Y-mAbs Therapeutics annual total expenses year-on-year change?
- What is Y-mAbs Therapeutics quarterly total expenses?
- What is the all time high quarterly total expenses for Y-mAbs Therapeutics?
- What is Y-mAbs Therapeutics quarterly total expenses year-on-year change?
What is Y-mAbs Therapeutics annual total expenses?
The current annual total expenses of YMAB is $110.49 M
What is the all time high annual total expenses for Y-mAbs Therapeutics?
Y-mAbs Therapeutics all-time high annual total expenses is $160.08 M
What is Y-mAbs Therapeutics annual total expenses year-on-year change?
Over the past year, YMAB annual total expenses has changed by -$49.59 M (-30.98%)
What is Y-mAbs Therapeutics quarterly total expenses?
The current quarterly total expenses of YMAB is $27.03 M
What is the all time high quarterly total expenses for Y-mAbs Therapeutics?
Y-mAbs Therapeutics all-time high quarterly total expenses is $50.74 M
What is Y-mAbs Therapeutics quarterly total expenses year-on-year change?
Over the past year, YMAB quarterly total expenses has changed by $0.00 (0.00%)